TY - JOUR
T1 - Measurement of small molecule binding kinetics on a protein microarray by plasmonic-based electrochemical impedance imaging
AU - Liang, Wenbin
AU - Wang, Shaopeng
AU - Festa, Fernanda
AU - Wiktor, Peter
AU - Wang, Wei
AU - Magee, Mitchell
AU - Labaer, Joshua
AU - Tao, Nongjian
N1 - Publisher Copyright:
© 2014 American Chemical Society.
PY - 2014/10/7
Y1 - 2014/10/7
N2 - We report on a quantitative study of small molecule binding kinetics on protein microarrays with plasmonic-based electrochemical impedance microscopy (P-EIM). P-EIM measures electrical impedance optically with high spatial resolution by converting a surface charge change to a surface plasmon resonance (SPR) image intensity change, and the signal is not scaled to the mass of the analyte. Using P-EIM, we measured binding kinetics and affinity between small molecule drugs (imatinib and SB202190) and their target proteins (kinases Abl1 and p38-α). The measured affinity values are consistent with reported values measured by an indirect competitive binding assay. We also found that SB202190 has weak bindings to ABL1 with KD > 10 μM, which is not reported in the literature. Furthermore, we found that P-EIM is less prone to nonspecific binding, a long-standing issue in SPR. Our results show that P-EIM is a novel method for high-throughput measurement of small molecule binding kinetics and affinity, which is critical to the understanding of small molecules in biological systems and discovery of small molecule drugs.
AB - We report on a quantitative study of small molecule binding kinetics on protein microarrays with plasmonic-based electrochemical impedance microscopy (P-EIM). P-EIM measures electrical impedance optically with high spatial resolution by converting a surface charge change to a surface plasmon resonance (SPR) image intensity change, and the signal is not scaled to the mass of the analyte. Using P-EIM, we measured binding kinetics and affinity between small molecule drugs (imatinib and SB202190) and their target proteins (kinases Abl1 and p38-α). The measured affinity values are consistent with reported values measured by an indirect competitive binding assay. We also found that SB202190 has weak bindings to ABL1 with KD > 10 μM, which is not reported in the literature. Furthermore, we found that P-EIM is less prone to nonspecific binding, a long-standing issue in SPR. Our results show that P-EIM is a novel method for high-throughput measurement of small molecule binding kinetics and affinity, which is critical to the understanding of small molecules in biological systems and discovery of small molecule drugs.
UR - http://www.scopus.com/inward/record.url?scp=84907929451&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84907929451&partnerID=8YFLogxK
U2 - 10.1021/ac5024556
DO - 10.1021/ac5024556
M3 - Article
AN - SCOPUS:84907929451
SN - 0003-2700
VL - 86
SP - 9860
EP - 9865
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 19
ER -